French biotech mergers and alliances “expected soon”
Announcements of alliances and mergers involving French biotechnology firms and pharmaceutical companies can be expected over the next few months, the industry group France Biotech has forecast
Watson gets FDA approval for BPH drug silodosin
Watson Pharmaceuticals, best-known as a generics company, has received approval from US regulators for Rapaflo, a new alpha blocker for the treatment of enlarged prostate
Servier may appeal after High Court loss to Apotex over perindopril
France’s Servier says it is disappointed by the decision of the UK High Court to award damages to generic drugmaker Apotex of £17.5 million in a patent dispute concerning its blood-pressure lowering drug Coversyl
|
 |
Biogen discontinues research on RA drug baminercept
Biogen Idec has suffered a setback with the news that disappointing data from a mid-stage trial means that the firm is to terminate development of investigational rheumatoid arthritis drug baminercept
EpiCept gets EU marketing approval for AML drug Ceplene
EpiCept Corp says that European regulators have given the green light to Ceplene, the US firm’s treatment for adults with acute myeloid leukaemia
"Virtual clinic' provides healthcare to rural areas of Pakistan
A ‘telemedicine’ system led by the US Department of State and computer giant IBM is bringing much-needed access to medical care to a remote area of Pakistan
|